Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK7580 Single-Dose Study in Peritoneal Dialysis Patients
NCT02143271Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Kyowa Kirin. Primary endpoint: Number and types of adverse events at 8 days. Started May 2014; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02143271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143271.